semaglutide alzheimer phase 3 Weight Loss Drug Shows Promise as Alzheimer's Treatment : ScienceAlert Two phase 3 trials testing

The weaker evidence is TRIUMPH-3, where hyperglycaemia was reported as an adverse event in 3.9% (9 mg) and 3.1% (12 mg) of retatrutide participants versus 13.4% on placebo

(2005) (2 R)-4-Oxo-4-[3-(trifluoromethyl)-5, 6-dihydro [1, 2, 4] triazolo [4, 3-a] pyrazin-7 (8 H)-yl]-1-(2, 4, 5-trifluorophenyl) butan-2-amine: a Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

Coskun T, Heise T, DeVries J et al (2022) Tirzepatide reduces appetite, energy intake and fat mass in people with type 2 diabetes

Toxins (Basel)

L68Q-hCC forms amyloid deposits in brain arteries associated with micro-infarcts, leading ultimately to paralysis, dementia and death in young adults

Protein shakes Helpful for mornings, rough appetite days, or the gap between I should eat and I cannot deal with food. A half shake still counts